Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Infection
|
April 9, 2024
Sapovirus: an emerging pathogen in kidney transplant recipients?
Michaela Rippl, Anton Burkhard-Meier, Ulf Schönermarck, et al.
Laryngo- Rhino- Otologie
|
December 21, 2022
[Cannabis in oncology - much ado about nothing?]
Anton Burkhard-Meier, Constanze Rémi, Lars H Lindner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 27, 2024
[Current therapeutic standards in advanced soft tissue sarcomas]
Anton Burkhard-Meier, Luc M Berclaz, Dorit Di Gioia, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 22, 2022
[Cannabis in oncology - much ado about nothing?]
Anton Burkhard-Meier, Constanze Rémi, Lars H Lindner, et al.
Anti-Cancer Drugs
|
October 7, 2022
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Klara Dorman, Anton Burkhard-Meier, Dorit Di Gioia, et al.
Annals of Surgical Oncology
|
August 29, 2025
Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia
Mathilda Knoblauch, Cathy Werdel, Yanik Arlt, et al.
Cancers
|
June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Journal of Cancer Research and Clinical Oncology
|
August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience
Luc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
BMC Cancer
|
April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
Luc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
BMC Cancer
|
March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment
Luc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Infection
|
April 9, 2024
Sapovirus: an emerging pathogen in kidney transplant recipients?
Michaela Rippl, Anton Burkhard-Meier, Ulf Schönermarck, et al.
Laryngo- Rhino- Otologie
|
December 21, 2022
[Cannabis in oncology - much ado about nothing?]
Anton Burkhard-Meier, Constanze Rémi, Lars H Lindner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 27, 2024
[Current therapeutic standards in advanced soft tissue sarcomas]
Anton Burkhard-Meier, Luc M Berclaz, Dorit Di Gioia, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 22, 2022
[Cannabis in oncology - much ado about nothing?]
Anton Burkhard-Meier, Constanze Rémi, Lars H Lindner, et al.
Anti-Cancer Drugs
|
October 7, 2022
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Klara Dorman, Anton Burkhard-Meier, Dorit Di Gioia, et al.
Annals of Surgical Oncology
|
August 29, 2025
Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional Hyperthermia
Mathilda Knoblauch, Cathy Werdel, Yanik Arlt, et al.
Cancers
|
June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Journal of Cancer Research and Clinical Oncology
|
August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience
Luc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
BMC Cancer
|
April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma
Luc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
BMC Cancer
|
March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment
Luc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Page
of 2